Citation Impact
Citing Papers
Role of α-Synuclein in Inducing Innate and Adaptive Immunity in Parkinson Disease
2015
Development of P assive I mmunotherapies for S ynucleinopathies
2015
Plasma β-amyloid in Alzheimer’s disease and vascular disease
2016 StandoutNobel
Microenvironmental modulation breaks intrinsic pH limitations of nanozymes to boost their activities
2024 StandoutNobel
Cognitive decline in Parkinson disease
2017
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
2016
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype
2016
Neuroligin 3 is a vertebrate gliotactin expressed in the olfactory ensheathing glia, a growth‐promoting class of macroglia
2001
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
2020 Standout
Parkinson disease
2017 Standout
Parkinson's disease
2021 Standout
Neurofilament light chain as a biomarker in neurological disorders
2019 Standout
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
2014
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
Mitochondrial Dysfunction and Immune Activation are Detectable in Early Alzheimer's Disease Blood
2012
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
2015 Standout
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
2018 Standout
The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias
2018
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Dissection of Synapse Induction by Neuroligins
2005 StandoutNobel
Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders
2016
Cerebrospinal fluid analysis in Alzheimer’s disease: technical issues and future developments
2014
CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders
2015
Neural plasticity: changes with age
2004
Structural Imaging in Parkinson’s Disease: New Developments
2019
Parkinson's disease
2015 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
2013
Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies
2015
Functional mapping and annotation of genetic associations with FUMA
2017 Standout
Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer’s disease patients and controls
2014
Traumatic spinal cord injury
2017 Standout
Small vessel disease: mechanisms and clinical implications
2019 Standout
Glia and alpha-synuclein in neurodegeneration: A complex interaction
2015
Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology
2015 StandoutNobel
Characterization of the Interaction of a Recombinant Soluble Neuroligin-1 with Neurexin-1β
2003 StandoutNobel
Amyloid biomarkers in Alzheimer's disease
2015
Genes Associated with Adult Axon Regeneration Promoted by Olfactory Ensheathing Cells: A New Role for Matrix Metalloproteinase 2
2006
The PI3K Pathway in Human Disease
2017 Standout
Down syndrome
2020 Standout
The associations between Parkinson’s disease and cancer: the plot thickens
2015
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
The amyloid hypothesis of Alzheimer's disease at 25 years
2016 Standout
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
2014
Age-Associated mRNA and miRNA Expression Changes in the Blood-Brain Barrier
2019 StandoutNobel
Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease
2015
Plasma neurofilament light chain predicts progression in progressive supranuclear palsy
2016
Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applications
2015
Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival
2017
The neuropathological diagnosis of Alzheimer’s disease
2019 Standout
Principles of Experience-Dependent Neural Plasticity: Implications for Rehabilitation After Brain Damage
2008 Standout
Neuroimmunological Processes in Parkinson’s Disease and their Relation to α-Synuclein: Microglia as the Referee between Neuronal Processes and Peripheral Immunity
2013
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Combination therapies: The next logical Step for the treatment of synucleinopathies?
2015
Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates
2014
Inflammation as a central mechanism in Alzheimer's disease
2018 Standout
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Gene Selection, Alternative Splicing, and Post-translational Processing Regulate Neuroligin Selectivity for β-Neurexins
2006 StandoutNobel
Adult Hippocampal Neurogenesis in Parkinson’s Disease: Impact on Neuronal Survival and Plasticity
2014
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Oxidative stress, mitochondrial damage and neurodegenerative diseases.
2013 Standout
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
2016
Religious Orders Study and Rush Memory and Aging Project
2018 Standout
Plasma tau in Alzheimer disease
2016 StandoutNobel
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer’s disease and other neurodegenerative diseases
2017
Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF
2015 StandoutNobel
The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease
2015
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
2019 Standout
Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status
2019
Insights into Neuroinflammation in Parkinson’s Disease: From Biomarkers to Anti-Inflammatory Based Therapies
2015
Works of Sara Hall being referenced
Blood-based NfL
2017
Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy
2015
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
2014
Alteration of putaminal fractional anisotropy in Parkinson’s disease: a longitudinal diffusion kurtosis imaging study
2018
Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairment
2011
Aβ1-15/16 as a Potential Diagnostic Marker in Neurodegenerative Diseases
2012
Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
2012
Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy
2013
Cerebrospinal fluid inflammatory markers in Parkinson’s disease – Associations with depression, fatigue, and cognitive impairment
2013
Adult rat olfactory nerve ensheathing cells are effective promoters of adult central nervous system neurite outgrowth in coculture
1999
Non-Motor Symptoms in Patients with Parkinson’s Disease – Correlations with Inflammatory Cytokines in Serum
2012
The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer’s but Not Parkinson’s Disease or Dementia with Lewy Bodies
2015
2016
CSF biomarkers and clinical progression of Parkinson disease
2014
Increased CSF biomarkers of angiogenesis in Parkinson disease
2015